GlassScriptPhysician profile
Ndi Geh
NPI 1073967725
$6,499.61
in general payments reported to CMS, 2019-2025
26 companies · $1,815 in 2025
The $1,815 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,667 · 2024: $3,018 · 2025: $1,815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,499.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,649.40 | 2023-2025 | Synthecel, Matrixneuro, Teligen |
| Penumbra, INC. | $794.60 | 2023-2025 | Red 72, Penumbra System |
| Stryker Corporation | $714.62 | 2023-2025 | Target, Axs Vecta 71, Trevo |
| Imperative Care, INC | $654.64 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Medtronic, INC. | $623.63 | 2023-2025 | Catalyft Pl Expandable Interbody System, Pipeline, Stealthstation S8 Platform |
| Microvention, INC. | $413.35 | 2023-2024 | Web Aneurysm Embolization System, Sofia 6f-131cm Str |
| Gt Medical Technologies, INC | $266.20 | 2023-2025 | Gammatile, Gammatile |
| Providence Medical Technology, INC. | $175.00 | 2025 | |
| Abbvie INC. | $166.56 | 2023-2024 | |
| Nevro Corp. | $149.48 | 2024 | Senza |
| Mml US, INC. | $116.17 | 2025 | Reactiv8 |
| Globus Medical, INC. | $115.44 | 2025 | Senza |
| Si-Bone, INC. | $108.71 | 2025 | |
| Balt USA, LLC | $103.89 | 2024 | Optima Coil System |
| Acadia Pharmaceuticals INC | $64.96 | 2024 | Daybue |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $62.38 | 2024 | Vyvgart Hytrulo |
| Ucb, INC. | $45.94 | 2024 | Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $44.16 | 2024 | Hyqvia |
| Octapharma USA, INC. | $40.00 | 2023-2024 | Panzyga |
| Ge Healthcare | $35.49 | 2024 | |
| Siemens Medical Solutions USA, INC. | $33.64 | 2023 | Artis Icono Biplane |
| Livanova USA, INC. | $32.21 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Heron Therapeutics, INC. | $31.62 | 2025 | Zynrelef |
| Boston Scientific Corporation | $20.67 | 2024 | |
| Immedica Pharma US, INC. | $19.43 | 2024 | |
| Abbott Laboratories | $17.42 | 2025 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ndi Geh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.